Ezibuy's parent company has appointed administrators - and this time it includes other brands including Katies and Millers. Mosaic Brands told the ASX it had received the support of a majority of its ...

(Heart) For patients with systolic heart failure and moderate aortic stenosis, preemptive transcatheter aortic valve replacement ... (JAMA Cardiology) Medtronic announced FDA approval of its ...

The disease causes a narrowing of the aortic valve, forcing the heart to work harder to pump blood. In a TAVR procedure, a replacement valve is threaded through the arteries to the heart via a ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Van Mieghem NM, Elmariah S, Spitzer E, et al. Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD. J Am Coll Cardiol 2024;Oct ...

This is because space is required to accommodate the excluded native aortic valve leaflets, which otherwise could compromise coronary arterial flow. Since the Medtronic CoreValve device is a much ...

After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest version of its transcatheter aortic valve replacement implant.

The Evolut FX+ transcatheter aortic valve replacement (TAVR) system. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Evolut FX+ ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Reviews ethics statement ...

Better yet, you'd... Shares of fertilizer producer The Mosaic Company surged over 5% Monday after the president of Belarus suggested trimming production of a key crop nutrient to boost prices.